Tumor molecular correlates of unresectable, locally advanced head and neck squamous cell carcinoma (SCCHN) response to concurrent radiation (RT), cisplatin (DDP), and cetuximab (C225) in a phase II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback